Supply-side opioid restrictions and the retail pharmacy market.

While policymakers routinely limit the sale of goods thought to be of risk to public health, relatively less is known about whether and how these policies affect firm performance. Using 2000-2018 National Establishment Time-Series data and a differen…

Preview only. Read the full abstract at the source